Doxorubicin Side Effects
Medically reviewed by Drugs.com. Last updated on Dec 8, 2022.
Commonly reported side effects of doxorubicin include: severe nausea and vomiting, nausea and vomiting, and alopecia. Continue reading for a comprehensive list of adverse effects.
Applies to doxorubicin: intravenous powder for solution, intravenous solution.
Intravenous route (Solution; Powder for Solution)
Myocardial damage can occur with DOXOrubicin hydrochloride with incidences from 1% to 20% for cumulative doses from 300 to 500 mg/m(2) when DOXOrubicin hydrochloride is administered every 3 weeks. The risk of cardiomyopathy is further increased with concomitant cardiotoxic therapy. Assess left ventricular ejection fraction (LVEF) before and regularly during and after treatment with DOXOrubicin hydrochloride. Secondary acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) occur at a higher incidence in patients treated with anthracyclines, including DOXOrubicin hydrochloride. Extravasation of DOXOrubicin hydrochloride can result in severe local tissue injury and necrosis requiring wide excision and skin grafting. Immediately terminate the drug, and apply ice to the affected area. Severe myelosuppression resulting in serious infection, septic shock, requirement for transfusions, hospitalization, and death may occur.
Serious side effects of Doxorubicin
Along with its needed effects, doxorubicin may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking doxorubicin:
- Cough or hoarseness accompanied by fever or chills
- darkening or redness of the skin (if you recently had radiation treatment)
- fast or irregular heartbeat
- fever or chills
- joint pain
- lower back or side pain accompanied by fever or chills
- pain at the injection site
- painful or difficult urination accompanied by fever or chills
- red streaks along the injected vein
- shortness of breath
- stomach pain
- swelling of the feet and lower legs
- Black, tarry stools
- blood in the urine
- pinpoint red spots on the skin
- unusual bleeding or bruising
Other side effects of Doxorubicin
Some side effects of doxorubicin may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
- Hair loss, thinning of hair
- nausea and vomiting
- sores in the mouth and on the lips
- Darkening of the soles, palms, or nails
After you stop using this medicine, it may still produce some side effects that need attention. During this period of time, Check with your doctor immediately if you notice the following side effects:
- Fast or irregular heartbeat
- shortness of breath
- swelling of the feet and lower legs
For Healthcare Professionals
Applies to doxorubicin: compounding powder, intravenous powder for injection, intravenous solution.
Common (1% to 10%): Cardiomyopathy, decreased LVEF, ECG changes (e.g., sinus tachycardia, tachyarrhythmia, ventricular tachycardia, bradycardia, bundle branch block), congestive heart failure
Very rare (less than 0.01%): Pericarditis, myocarditis
Postmarketing reports: Cardiogenic shock, phlebosclerosis, phlebitis/thrombophlebitis, hot flashes, thromboembolism[Ref]
Very common (10% or more): Leucopenia (60% to 80%)
Common (1% to 10%): Bone marrow suppression
Uncommon (0.1% to 1%): Thrombocytopenia[Ref]
Common (1% to 10%): Alopecia
Rare (less than 0.1%): Urticaria, exanthema, local erythematous reactions along the vein which was used for the injection, hyperpigmentation of skin and nails, onycholysis
Postmarketing reports: Oncolysis, rash, itching, photosensitivity, urticaria, acral erythema, palmar plantar erythrodysesthesia[Ref]
Very common (10% or more): Nausea and vomiting (20% to 85%), stomatitis (up to 80%), diarrhea (12%)
Common (1% to 10%): Mucositis
Uncommon (0.1% to 1%): Ulceration and necrosis of the colon, especially the cecum (in combination with cytarabine)[Ref]
Frequency not reported: Extravasation, tissue necrosis[Ref]
Rare (0.01% to 0.1%): Anaphylactic reactions[Ref]
Rare (0.01% to 0.1%): Renal insufficiency[Ref]
Rare (0.01% to 0.1%): Shivering, fever
Frequency not reported: Radiation recall
Postmarketing reports: Malaise, asthenia, fever, chills[Ref]
Common (1% to 10%): Secondary malignancies[Ref]
Rare (0.01% to 0.1%): Conjunctivitis
Postmarketing reports: Keratitis, lacrimation[Ref]
Common (1% to 10%): Local reactions (chemical cystitis) may occur with intravesical treatment
Rare (less than 0.1%): Bladder contracture
Frequency not reported: Amenorrhea[Ref]
Common (1% to 10%): Anorexia
Frequency not reported: Hyperuricemia, tumor lysis syndrome
Postmarketing reports: Weight gain[Ref]
Postmarketing reports: Increased alanine aminotransferase, increased aspartate aminotransferase[Ref]
Common (1% to 10%): Dyspnea
Frequency not reported: Bronchospasm, cough, epistaxis, pneumonia, nasopharyngitis, upper respiratory tract infection[Ref]
Rare (0.01% to 0.1%): Dizziness
Postmarketing reports: Peripheral sensory and motor neuropathy, seizures, coma[Ref]
Frequently asked questions
- What is the chemo drug called the Red Devil?
- What is the strongest chemotherapy drug for breast cancer?
- What is the lifetime or cumulative dose for Adriamycin?
- How does AC (Adriamycin and Cytoxan [cyclophosphamide]) work for Breast Cancer?
- What are the long-term side effects of Adriamycin?
- Does Adriamycin cause heart failure?
- How is Lartruvo administered?
More about doxorubicin
- Check interactions
- Pricing & coupons
- Reviews (9)
- Dosage information
- During pregnancy
- Drug class: antibiotics/antineoplastics
- En español
Related treatment guides
1. "Product Information. Adriamycin PFS (doxorubicin)." Pharmacia and Upjohn (2001):
2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.